Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net Income (Loss)	$ 374,816	$ 397,025
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	30,438	26,848
Amortization	6,598	6,514
Share-based compensation	17,385	14,391
Equity in earnings of unconsolidated investments, net	(56)	(180)
Other	459	3,123
Changes in operating assets and liabilities, net of effects of acquisitions:
Receivables	(123,914)	(80,362)
Product inventories	77,407	181,326
Prepaid expenses and other assets	73,226	57,151
Accounts payable	(69,794)	(109,021)
Accrued expenses and other liabilities	(100,822)	(8,196)
Net cash provided by operating activities	285,743	488,619
Investing activities
Acquisition of businesses, net of cash acquired	(7,116)	(4,435)
Purchases of property and equipment, net of sale proceeds	(48,123)	(45,951)
Other investments, net	(508)	944
Net cash used in investing activities	(55,747)	(49,442)
Financing activities
Proceeds from revolving line of credit	1,417,100	1,146,900
Payments on revolving line of credit	(1,390,400)	(1,274,400)
Proceeds from term loan under credit facility	125,000	0
Payments on term loan under credit facility	(87,500)	(18,750)
Proceeds from asset-backed financing	437,600	623,900
Payments on asset-backed financing	(370,400)	(606,300)
Payments on term facility	(19,938)	0
Proceeds from short-term borrowings and current portion of long-term debt	17,431	8,873
Payments on short-term borrowings and current portion of long-term debt	(16,523)	(8,643)
Payments of deferred financing costs	(1,397)	(1,731)
Proceeds from stock issued under share-based compensation plans	9,203	11,955
Payments of cash dividends	(138,664)	(134,181)
Repurchases of common stock	(163,884)	(159,408)
Net cash used in financing activities	(182,372)	(411,785)
Effect of exchange rate changes on cash and cash equivalents	2,997	(2,585)
Change in cash and cash equivalents	50,621	24,807
Cash and cash equivalents at beginning of period	77,862	66,540
Cash and cash equivalents at end of period	$ 128,483	$ 91,347